Skin culture model: A possible alternative to the use of excised human skin for assessing in vitro percutaneous absorption

Toxicology in Vitro

Volumn 12, Issue 4, 1998, Pages 423-430

  Doucet, O ^a   Garcia, N ^a   Zastrow, L ^a  

^a International Research Center   (Monaco)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ACETYLSALICYLIC ACID; BENZOIC ACID; CAFFEINE; DRUG VEHICLE; NICOTINIC ACID; PANTOTHENIC ACID; SALICYLIC ACID; SCOPOLAMINE; TESTOSTERONE; THEOPHYLLINE;

ARTICLE; DRUG DIFFUSION; DRUG PENETRATION; DRUG SCREENING; EPIDERMIS; HUMAN; HUMAN TISSUE; SKIN ABSORPTION; SKIN CULTURE;

EID: 0031859447     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(98)00023-X     Document Type: Article

References (27)

1. Anjo D. M., Feldman R. J. and Maibach H. I. (1980) Methods for predicting percutaneous penetration in man. In Percutaneous Penetration of Steroids. Edited by P. Mauvais-Jarvais. pp. 31-51. Academic Press, New York.
2. Barratt M. D. (1995) Quantitative structure-activity relationships for skin permeability. Toxicology in Vitro 9, 27-37.
3. Bronaugh R. L. (1993) Diffusion cell design. In Topical Drug Bioavailability, Bioequivalence and Penetration. Edited by V. P. Shaw and H. I. Maibach. pp. 117-125. Plenum Press, New York.
4. Bronaugh R. L. and Franz T. J. (1986) Vehicle effects on percutaneous absorption: in vivo and in vitro comparison with human skin. British Journal of Dermatology 115, 1-11.
5. Bronaugh R. L. and Stewart R. F. (1985) Methods for in vitro percutaneous absorption studies. IV: The flow through diffusion cell. Journal of Pharmaceutical Sciences 74, 474-480.
6. Cohen C., Dossou G., Rougier A. and Roguet R. (1994) Episkin: an in vitro model for the evaluation of the phototoxicity and sunscreen photoprotective properties. Toxicology in Vitro 8, 669-671.
7. COLIPA (1995) Cosmetic ingredients, guidelines for percutaneous absorption/penetration. The European Cosmetic, Toiletry and Perfumery Association, Brussels.
8. Doucet O., Robert C. and Zastrow L. (1996) Use of a serum-free reconstituted epidermis as a skin pharmacological model. Toxicology in Vitro 3, 305-313.
9. Elias P. M. (1995) Role of lipids in barrier function of the skin. In Pharmacology of the Skin. Edited by H. Mukhtar. pp. 29-38. CRC Press Boca Raton, Ann Arbor.
10. Fartasch M. and Ponec M. (1994) Improved barrier structure formation in air exposed human keratinocyte culture. Journal of Investigative Dermatology 102, 366-374.
11. Fartasch M., Ponec M. and Rosdy M. (1996) The development of a structurally competent epidermal barrier in air-exposed keratinocytes cultures: a time course study. Abstract, 23rd Annual Meeting of the Society for Cutaneous Ultrastructure Research (April 11-13). Journal of Investigative Dermatology 107, 656.
12. Franz T. J. (1975) Percutaneous absorption. On the relevance of in vitro data. Journal of Investigative Dermatology 64, 190-195.
13. Gay R., Swiderek M., Nelson D. and Ernesti A. (1992) The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants. Toxicology in Vitro 6, 303-315.
14. Guy R. H., Carlstom E. M., Bucks D. A. W., Hinz R. S. and Maibach H. I. (1986) Percutaneous penetration of nicotinates: in vivo and in vitro measurements. Journal of Pharmaceutical Sciences 75, 968-972.
15. Hou S. Y. E., Mitra A. K., White S. H., Menon G. K., Ghadially R. and Elias P. M. (1991) Membrane structure in normal and essential fatty acid deficient stratum corneum: characterized by ruthenium tetroxide staining and X ray diffraction. Journal of Investigative Dermatology 96, 215-223.
16. Howes D., Guy R., Hadgraft J., Heylings J., Hoeck U., Kemper F., Maibach H. I., Marty J. P., Merck H., Parra J., Rekkas D., Rondelli I., Schaefer H., Tauber U. and Verbiese N. (1996) Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop report 13. ATLA 24, 81-106.
17. Madison K. C., Swartzendruber D. C., Wertz P. W. and Downing D. T. (1988) Lamellar granule extrusion and stratum corneum intercellular lamellae in murine keratinocyte cultures. Journal of Investigative Dermatology 90, 110-116.
18. Ponec M. and Kempenaar J. (1995) Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritant. Skin Pharmacology 8, 49-59.
19. Ponec M., Wauben-Penris P. J. J., Burger A., Kempenaar J. and Boddé H. E. (1990) Nitroglycerin and sucrose permeability as quality markers for reconstructed human epidermis. Skin Pharmacology 3, 126-135.
20. Ponec M., Weerheim A., Kempenaar J., Mommaas A. M. and Nugteren D. H. (1988) Lipids composition of cultured human keratinocytes in relation to their differentiation. Journal of Lipid Research 29, 949-961.
21. Potts R. O. and Francoeur M. L. (1991) The influence of stratum corneum morphology on water permeability. Journal of Investigative Dermatology 96, 495-499.
22. Regnier M., Caron D., Reichert U. and Schaefer H. (1992) Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacology 5, 49-56.
23. Rosdy M. and Clauss L. C. (1990) Terminal epidermal differentiation of human keratinocytes grown in chemically-defined medium on inert filter substrates at the air liquid interface. Journal of Investigative Dermatology 95, 409-414.
24. Rosdy M., Pisani A. and Ortonne J. P. (1993) Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factors. British Journal of Dermatology 129, 227-234.
25. Roskos K. V., Maibach H. I. and Guy R. H. (1989) The effect of aging on percutaneous absorption in man. Journal of Pharmacokinetics and Biopharmaceutics 17, 617-630.
26. Scheuplein R. J. (1976) Permeability of the skin : a review of major concepts and some new developments. Journal of Investigative Dermatology 67, 672.
27. Skelly J. P., Shah P., Maibach H. I., Guy R. H., Wester R. C., Flynn G. and Yacobi A. (1987) FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: Relevance to bioavailability and bioequivalence. Pharmaceutical Research 4, 265-267.